CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 30 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $244,000 | -34.8% | 1,037,871 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $374,000 | -30.7% | 1,037,871 | 0.0% | 0.00% | -40.0% |
| Q3 2017 | $540,000 | -11.2% | 1,037,871 | -0.9% | 0.01% | 0.0% |
| Q2 2017 | $608,000 | -67.2% | 1,047,731 | 0.0% | 0.01% | -72.2% |
| Q1 2017 | $1,854,000 | +47.5% | 1,047,731 | 0.0% | 0.02% | +28.6% |
| Q4 2016 | $1,257,000 | +4555.6% | 1,047,731 | +7984.3% | 0.01% | – |
| Q3 2015 | $27,000 | – | 12,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospera Financial Services Inc | 176,100 | $287,000 | 0.05% |
| RFG Advisory, LLC | 40,000 | $65,000 | 0.05% |
| Acrospire Investment Management LLC | 16,551 | $29,000 | 0.02% |
| HighTower Advisors, LLC | 1,047,731 | $1,854,000 | 0.02% |
| B. Riley Wealth Advisors, Inc. | 25,958 | $46,000 | 0.01% |
| EXENCIAL WEALTH ADVISORS, LLC | 11,900 | $19,000 | 0.01% |
| THOMPSON DAVIS & CO., INC. | 3,000 | $5,000 | 0.01% |
| LBA Wealth Management, LLC | 8,000 | $14,000 | 0.01% |
| INGALLS & SNYDER LLC | 20,739 | $37,000 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $2,000 | 0.00% |